Worth reading
44Recurring
Scored from 5 of 6 sectionsDirection
Mixed performance
Direction inferred from the company’s description.Scale
43.7
% (year-on-year change in interim net income attributable to owners of the parent)Wording
Conditional
How definitive the wording is.Results for this period
Interim period (second quarter)2025年4月1日〜2025年9月30日ConsolidatedJapanese GAAPNet Sales16,667¥ millionYear on year +3.1%Progress 51.8%
Operating profit1,448¥ millionYear on year +1.9%Progress 57.9%
Ordinary income1,570¥ millionYear on year +4.3%Progress 56.1%
Net income attributable to owners of the parent1,516¥ millionYear on year +43.7%Progress 63.2%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share55円21銭
Financial position at period-end
Total assets30,540¥ million
of which net assets 18,203 ¥ millionEquity ratio 59.6%vs. prior year-end +3.1pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+1,020
Investment+869
Financials-1,253
Net change+636
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥3,947 million
Segment revenueSugar business ¥15,834 million (YoY +3.4%), Bio Business ¥847 million (YoY +1.0%), Other ¥68 million (YoY +0.8%)
Segment profitSugar business ¥1,973 million (YoY +4.0%), Bio Business ¥160 million (YoY -14.2%), Other ¥38 million (YoY -1.1%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥32,200 million (YoY -1.0%)
Operating profit¥2,500 million (YoY -13.2%)
Ordinary income¥2,800 million (YoY -8.3%)
Net income¥2,400 million (YoY +12.3%)
Annual Dividend Forecast¥15 → ¥15（0.0%）
Factors Behind Changes in Business Performance
砂糖事業は、家庭用製品が低調だった一方、インバウンド・観光需要、記録的な猛暑を背景に業務用製品や飲料ユーザー向けの販売が好調となり、販売数量・売上高が増加。バイオ事業は一部家庭用・業務用製品が低調で、原材料コスト等の上昇によりセグメント利益が減少。投資有価証券売却益605百万円を計上。
Disclosure regarding the going concern assumption
No applicable matters ("There are no applicable matters")
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNo material changes (number and names of companies newly consolidated or excluded: Not disclosed)
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥605 million / Extraordinary loss Not disclosed
Depreciation and amortization¥289 million
Availability of Supplementary Financial Results MaterialsNo
Availability of Financial Results BriefingNone (対象者：Not disclosed)
Issued Shares at Period-End35,000,000
Treasury Shares at Period-End7,477,429
| Item | Details |
|---|---|
| Fiscal Period Classification | Interim period (second quarter) |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 2025年4月1日〜2025年9月30日 |
| Net Sales | ¥16,667 million (YoY +3.1%) |
| Operating profit | ¥1,448 million (YoY +1.9%) |
| Ordinary income | ¥1,570 million (YoY +4.3%) |
| Profit attributable to owners of the parent | ¥1,516 million (YoY +43.7%) |
| Net income per share | 55円21銭 |
| Equity ratio | End of the current fiscal period 59.6 / End of previous period 56.5 |
| Total assets | ¥30,540 million |
| Net assets | ¥18,203 million |
| Cash flows from operating activities | ¥1,020 million |
| Cash flows from investing activities | ¥869 million |
| Cash flows from financing activities | ¥-1,253 million |
| Cash and cash equivalents at end of period | ¥3,947 million |
| Full-year earnings forecast | Net Sales ¥32,200 million (YoY -1.0%) / Operating profit ¥2,500 million (YoY -13.2%) / Ordinary income ¥2,800 million (YoY -8.3%) / Net income ¥2,400 million (YoY +12.3%) |
| Annual Dividend Forecast | ¥15 → ¥15（0.0%） |
| Segment revenue | Sugar business ¥15,834 million (YoY +3.4%), Bio Business ¥847 million (YoY +1.0%), Other ¥68 million (YoY +0.8%) |
| Segment profit | Sugar business ¥1,973 million (YoY +4.0%), Bio Business ¥160 million (YoY -14.2%), Other ¥38 million (YoY -1.1%) |
| Depreciation and amortization | ¥289 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥605 million / Extraordinary loss Not disclosed |
| Disclosure regarding the going concern assumption | No applicable matters ("There are no applicable matters") |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No material changes (number and names of companies newly consolidated or excluded: Not disclosed) |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | None (対象者：Not disclosed) |
| Issued Shares at Period-End | 35,000,000 |
| Treasury Shares at Period-End | 7,477,429 |
| Factors Behind Changes in Business Performance | 砂糖事業は、家庭用製品が低調だった一方、インバウンド・観光需要、記録的な猛暑を背景に業務用製品や飲料ユーザー向けの販売が好調となり、販売数量・売上高が増加。バイオ事業は一部家庭用・業務用製品が低調で、原材料コスト等の上昇によりセグメント利益が減少。投資有価証券売却益605百万円を計上。 |
Items this document does not state (8)
Operating MarginRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment lossMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.砂糖事業では、インバウンド・観光需要や記録的な猛暑を背景に業務用製品や飲料ユーザー向けの販売が好調で、販売数量・売上高が増加した。バイオ事業では原材料コスト等の上昇で利益が減少した。最終利益は投資有価証券売却益605百万円を計上したことにより増加した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.